Correlations between negative symptoms, physical activity and metabolic syndrome in patients with schizophrenia - a literature review

被引:0
作者
Casadei, Veronica [1 ,2 ]
Jaracz, Jan [1 ]
Wojciak, Pawel [1 ]
Rybakowski, Filip [1 ]
机构
[1] Uniwersytet Med im K Marcinkowskiego Poznaiu, Klinika Psychiatrii Doroslych, Poznan, Poland
[2] Uniwersytet Med im K Marcinkowskiegoul, Klinika Psychiatrii Doroslych, ul Szpitalna 27-33, PL-60572 Poznan, Poland
来源
NEUROPSYCHIATRIA I NEUROPSYCHOLOGIA | 2022年 / 17卷 / 3-4期
关键词
schizophrenia; physical activity; negative symptoms; metabolic syndrome; SEDENTARY BEHAVIOR; ASSOCIATION; PREVALENCE; OVERWEIGHT; PSYCHOSIS; INSULIN; IMPACT;
D O I
10.5114/nan.2022.124689
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In schizophrenia patients, metabolic syndrome occurs more often than in the general population, causing increased morbidity and mortality. In this paper, we review data concerning potential causes of metabolic syndrome. The purpose of this study is to highlight various arguments in the discussion about metabolic syndrome in patients with schizophrenia. The impor-tance of the negative symptoms and physical activity as factors which have a significant impact on develop-ment of metabolic syndrome components is especially underlined. The scientific reports referring to already studied correlations between metabolic syndrome, its particular criteria (according to the National Cholesterol Education Program Adult Treatment Panel III) and its probable causes are presented. The potential role of antipsychotic medications and the pathogene-sis of metabolic abnormalities in antipsychotic-naive first-episode schizophrenia patients are also discussed. Those issues are frequently mentioned in the debate about the explored phenomena. In previous studies, cross-sectional methodology has been applied and the authors used subjective tools, such as scales and ques-tionnaires, to assess physical activity, which may raise doubts as to the value of such measurements. Results which have been published so far are contradictory and are not sufficient to create consistent guidelines of clin-ical management of metabolic syndrome in patients with schizophrenia. For better understanding of poten-tial relationships, further multicenter research using objective methods of evaluating physical activity, such as accelerometry, is required. That might contribute to implementing therapeutic programs to decrease mor-tality among schizophrenia patients.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 38 条
[1]   Metabolic syndrome in patients with schizophrenia and antipsychotic treatment [J].
Aguilar, Eva ;
Coronas, Ramon ;
Caixas, Assumpta .
MEDICINA CLINICA, 2012, 139 (12) :542-546
[2]   Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: Severe negative syndrome may be related to a distinct lipid pathophysiology [J].
Chen, S. -F. ;
Hu, T. -M. ;
Lan, T. -H. ;
Chiu, H. -J. ;
Sheen, L. -Y. ;
Loh, E. -W. .
EUROPEAN PSYCHIATRY, 2014, 29 (03) :167-171
[3]   Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia [J].
Chen, Song ;
Broqueres-You, Dong ;
Yang, Guigang ;
Wang, Zhiren ;
Li, Yanli ;
Wang, Ning ;
Zhang, Xiangyang ;
Yang, Fude ;
Tan, Yunlong .
PSYCHIATRY RESEARCH, 2013, 210 (03) :825-829
[4]   Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication [J].
De Hert, MA ;
van Winkel, R ;
Van Eyck, D ;
Hanssens, L ;
Wampers, M ;
Scheen, A ;
Peuskens, J .
SCHIZOPHRENIA RESEARCH, 2006, 83 (01) :87-93
[5]   Impact of primary negative symptoms on functional outcomes in schizophrenia [J].
Fervaha, G. ;
Foussias, G. ;
Agid, O. ;
Remington, G. .
EUROPEAN PSYCHIATRY, 2014, 29 (07) :449-455
[6]   Neurobiological background of negative symptoms [J].
Galderisi, Silvana ;
Merlotti, Eleonora ;
Mucci, Armida .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2015, 265 (07) :543-558
[7]   Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis [J].
Gjerde, Priyanthi B. ;
Dieset, Ingrid ;
Simonsen, Carmen ;
Hoseth, Eva Z. ;
Iversen, Trude ;
Lagerberg, Trine V. ;
Lyngstad, Siv Hege ;
Morch, Ragni H. ;
Skrede, Silje ;
Andreassen, Ole A. ;
Melle, Ingrid ;
Steen, Vidar M. .
SCHIZOPHRENIA RESEARCH, 2018, 197 :253-260
[8]   Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample [J].
Gurpegui, Manuel ;
Maria Martinez-Ortega, Jose ;
Gutierrez-Rojas, Luis ;
Rivero, Juan ;
Rojas, Cristina ;
Jurado, Dolores .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 37 (01) :169-175
[9]   The association between weight change and symptom reduction in the CATIE schizophrenia trial [J].
Hermes, Eric ;
Nasrallah, Henry ;
Davis, Vicki ;
Meyer, Jonathan ;
McEvoy, Joseph ;
Goff, Donald ;
Davis, Sonia ;
Stroup, T. Scott ;
Swartz, Marvin ;
Lieberman, Jeffrey ;
Rosenheck, Robert .
SCHIZOPHRENIA RESEARCH, 2011, 128 (1-3) :166-170
[10]   Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis [J].
Hjorthoj, Carsten ;
Sturup, Anne Emilie ;
McGrath, John J. ;
Nordentoft, Merete .
LANCET PSYCHIATRY, 2017, 4 (04) :295-301